Silexion Therapeutics Corp [NASDAQ: SLXN] slipped around 0.0 points on Thursday, while shares priced at $0.96 at the close of the session, down -0.41%.
Compared to the average trading volume of 3.10M shares, SLXN reached a trading volume of 12493905 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Silexion Therapeutics Corp [SLXN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLXN shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLXN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Silexion Therapeutics Corp is set at 0.10 The Price to Book ratio for the last quarter was 3.23, with the Price to Cash per share for the same quarter was set at 0.71.
How has SLXN stock performed recently?
Silexion Therapeutics Corp [SLXN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 4.27. With this latest performance, SLXN shares gained by 6.67% in over the last four-week period, additionally sinking by -65.26% over the last 6 months – not to mention a drop of -99.02% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SLXN stock in for the last two-week period is set at 49.51, with the RSI for the last a single of trading hit 49.22, and the three-weeks RSI is set at 48.41 for Silexion Therapeutics Corp [SLXN]. The present Moving Average for the last 50 days of trading for this stock 0.9571, while it was recorded at 0.9911 for the last single week of trading.
Silexion Therapeutics Corp [SLXN]: Deeper insight into the fundamentals
Silexion Therapeutics Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.22 and a Current Ratio set at 3.22.
Earnings analysis for Silexion Therapeutics Corp [SLXN]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SLXN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Silexion Therapeutics Corp go to 63.05%.
